AJRR Press Releases
Rosemont, Ill. – June 23, 2017 – The American Joint Replacement Registry (AJRR), a clinical data registry for the collection of hip and knee replacement data, was awarded the “Best Poster Presentation” by the International Society of Arthroplasty Registries (ISAR) at the 6th International Congress of Arthroplasty Registries meeting last month. The poster, “Infection burden in total hip and knee arthroplasty: an international registry based perspective,” was based on an original research article published in the June issue of Arthroplasty Today.
AJRR and ASCA partner to validate the effectiveness of outpatient surgery centers
Rosemont, Ill. - March 7, 2017 - The American Joint Replacement Registry (AJRR) and the Ambulatory Surgery Center Association (ASCA) announce they have entered into a collaborative relationship to encourage ASCA-member ambulatory surgery centers (ASCs) to register in the AJRR. Registry participation, and the data that will be complied, will be used to validate current efforts to reduce health care costs by moving total joint replacements to Medicare's ASC-payable list and expanding the number of private payers that will reimburse ASCs for these procedures.
AJRR's data collection helps providers improve patient care
Rosemont, Ill. - March 14, 2017 - The American Joint Replacement Registry (AJRR), the National Registry for the collection of hip and knee replacement data, has reached the one millionth hip and knee procedure milestone. This increased volume of data will lead to a more comprehensive look at joint replacement surgeries in America, and will aid hospital staff and patients in making better health care decisions.
AJRR participants can now submit Level II data
Rosemont, Ill. - March 14, 2017 - The American Joint Replacement Registry (AJRR), the Registry for the collection of hip and knee replacement data, has released new data specifications that allow for health care institutions to collect and report on patient risk factors, comorbidities, and complications data. This data is known as Level II, and is either required or recommended by several federal and state quality initiatives. The addition of Level II completes our dataset, and gives Registry participants risk adjusted data that they can use to determine survivorship curves.